Emergence of Extensively Drug-Resistant <i>Neisseria gonorrhoeae,</i> France, 2023
François Caméléna, Manel Mérimèche, Julie Brousseau, Mary Mainardis, Pascale Verger, Caroll Le Risbé, Élise Brottet, A. Thabuis, Cécile Bébéar, Jean‐Michel Molina, Florence Lot, Émilie Chazelle, Béatrice Berçot
Abstract
Since 2022, Europe has had 4 cases of extensively drug-resistant Neisseria gonorrhoeae, sequence type 16406, that is resistant to ceftriaxone and highly resistant to azithromycin. We report 2 new cases from France in 2023 involving strains genetically related to the 4 cases from Europe as well as isolates from Cambodia.
Topics & Concepts
Neisseria gonorrhoeaeAzithromycinCeftriaxoneMicrobiologyDrug resistanceBiologyNeisseriaVirologyAntibioticsMedicineBacteriaGeneticsReproductive tract infections researchBacterial Infections and VaccinesSyphilis Diagnosis and Treatment